Categories Cannabis, Earnings

Neptune Wellness (NEPT) Q2 loss widens on lower revenues; inks production deal with IFF

Neptune Wellness Solutions (NASDAQ: NEPT) reported a sharply wider net loss for the second quarter of 2020 as revenues declined 8%. The company said it signed an agreement with International Flavors & Fragrances to co-develop hemp-derived CBD products.

The Quebec, Canada-based cannabinoids extraction company reported a net loss of C$20.78 million for the September-quarter, compared to a loss of C$3.05 million a year earlier. The deterioration in performance is mainly attributable to an increase in costs related to stock-based compensation, depreciation, and amortization.

Revenues down 8%

Second-quarter revenues dropped 8% annually to C$6.5 million from last year’s revenue of C$7.07 million. Revenues from the Nutraceutical segment decreased by 27% to C$5.1 million. Adjusted EBITDA1 was a loss of $4.58 million, down from the year-ago period.

Also see: Neptune Wellness Solutions loss widens in Q1

“We achieved a significant milestone in mid-October when we completed our Phase II capacity expansion. This additional capacity will alleviate our constraints in the near-term and help accelerate the company’s revenue growth in the cannabis segment. However, the start-up of our ethanol process has been longer than initially expected which has delayed the full ramp-up by one month to the end of December,” said CEO Michael Cammarata.

Outlook

Neptune said it is well-positioned to leverage the strong demand for extraction services in Canada and continue to diversify its client base in the coming months. The facility in North Carolina, U.S, is expected to reach a processing capacity of 1,500,000 kg of biomass annually by the end of December.

During the quarter, the company completed the acquisition of the assets of SugarLeaf, for initial consideration of C$23.7 million. It also announced the creation of Neptune Ventures, a strategic investment arm and technology incubator designed to stimulate innovation and partnerships in the cannabis and wellness industries.

IFF Agreement

Separately, the company said it entered into an agreement with International Flavors & Fragrances (IFF) to co-develop hemp-derived CBD products for the retail and health & wellness markets. The deal will help Neptune leverage its proprietary cold ethanol extraction processes and formulation IP to deliver extracts for hemp-derived products infused with essential oils.

Related: Neptune Q4 2019 Earnings Conference Call Transcript

Neptune’s shares have been on a losing streak since hitting a record high in July. The stock closed the last trading session slightly higher in the Nasdaq stock exchange.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top